Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (3-(2-methyl-5-nitroimidazol-1-yl)-propan-1-ol)
2. 3-(2-methyl-5-nitroimidazol-1-yl)-propan-1-ol
1. 1077-93-6
2. Ternidazole [inn]
3. 3-(2-methyl-5-nitroimidazol-1-yl)propan-1-ol
4. 4n8r018qb0
5. 3-(2-methyl-5-nitro-1h-imidazol-1-yl)propan-1-ol
6. Ternidazol
7. Ternidazolum
8. Ternidazol [inn-spanish]
9. Ternidazolum [inn-latin]
10. 1-(3-hydroxypropyl)-2-methyl-5-nitro-1h-imidazole
11. Unii-4n8r018qb0
12. Einecs 214-077-5
13. 1h-imidazole-1-propanol, 2-methyl-5-nitro-
14. Ternidazole [mart.]
15. Ternidazole [who-dd]
16. Chembl185647
17. Schembl2108944
18. Dtxsid60862525
19. Zinc1846040
20. 2-methyl-5-nitroimidazole-1-propanol
21. Akos006271736
22. Am90173
23. Ft-0691786
24. 1-(3-hydroxypropyl)-2-methyl-5-nitroimidazole
25. 077t936
26. 3-(2-methyl-5-nitroimidazol-1-yl)-propan-1-ol
27. (3-(2-methyl-5-nitroimidazol-1-yl)-propan-1-ol)
28. Q27260224
| Molecular Weight | 185.18 g/mol |
|---|---|
| Molecular Formula | C7H11N3O3 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 185.08004122 g/mol |
| Monoisotopic Mass | 185.08004122 g/mol |
| Topological Polar Surface Area | 83.9 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 182 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Ternidazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ternidazole, including repackagers and relabelers. The FDA regulates Ternidazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ternidazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ternidazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ternidazole supplier is an individual or a company that provides Ternidazole active pharmaceutical ingredient (API) or Ternidazole finished formulations upon request. The Ternidazole suppliers may include Ternidazole API manufacturers, exporters, distributors and traders.
click here to find a list of Ternidazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ternidazole written confirmation (Ternidazole WC) is an official document issued by a regulatory agency to a Ternidazole manufacturer, verifying that the manufacturing facility of a Ternidazole active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ternidazole APIs or Ternidazole finished pharmaceutical products to another nation, regulatory agencies frequently require a Ternidazole WC (written confirmation) as part of the regulatory process.
click here to find a list of Ternidazole suppliers with Written Confirmation (WC) on PharmaCompass.
Ternidazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ternidazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ternidazole GMP manufacturer or Ternidazole GMP API supplier for your needs.
A Ternidazole CoA (Certificate of Analysis) is a formal document that attests to Ternidazole's compliance with Ternidazole specifications and serves as a tool for batch-level quality control.
Ternidazole CoA mostly includes findings from lab analyses of a specific batch. For each Ternidazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ternidazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Ternidazole EP), Ternidazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ternidazole USP).
LOOKING FOR A SUPPLIER?
